Efficacy of tacrolimus and i.v.[intravenous] -immunoglobulins in Rasmussen encephalitis with start of treatment in the acute disease stage. prospective, randomised, open parallel group study
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 18 Apr 2009
At a glance
- Drugs Immunoglobulins; Tacrolimus
- Indications Encephalitis
- Focus Therapeutic Use
- 18 Apr 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Dec 2008 Planned number of patients identified as 16 from ClinicalTrials.gov.
- 01 Dec 2008 Planned end date identified as 1 Jul 2010 from ClinicalTrials.gov.